---
figid: PMC9315303__gr7
figtitle: Genistein promotes M1 macrophage apoptosis and reduces inflammatory response
  by disrupting miR-21/TIPE2 pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Candida dubliniensis
- Ipomoea batatas
- Homo sapiens
- Clostridium perfringens
- Celithemis elisa
pmcid: PMC9315303
filename: gr7.jpg
figlink: /pmc/articles/PMC9315303/figure/f0035/
number: F7
caption: Working model for genistein promotes M1 macrophage apoptosis and reduces
  inflammatory response in LPS-induced cardiovascular injury. Genistein regulates
  NF-κB/miR-21/TIPE2 signaling pathway, which on the one hand leads to inhibition
  of downstream AKT phosphorylation and promotes apoptosis of M1 macrophages, and
  on the other hand down-regulates TRIF and MyD88 expressions to reduce inflammation.
  As a result, it can resist LPS-induced cardiovascular injury.
papertitle: Genistein promotes M1 macrophage apoptosis and reduces inflammatory response
  by disrupting miR-21/TIPE2 pathway.
reftext: Li Cong, et al. Saudi Pharm J. 2022 Jul;30(7):934-945.
year: '2022'
doi: 10.1016/j.jsps.2022.05.009
journal_title: 'Saudi Pharmaceutical Journal : SPJ'
journal_nlm_ta: Saudi Pharm J
publisher_name: Elsevier
keywords: Genistein | miR-21 | Tumor necrosis factor-α-induced protein 8-like 2 |
  Lipopolysaccharide | Macrophage apoptosis | Inflammatory response | 3′ UTR, 3′ untranslated
  region | ABCG1, ATP‐binding cassette transporter G1 | AKT, protein kinase B | AP-1,
  activating protein-1 | BAX, BCL-2 associated X | BCL-2, B cell lymphoma-2 | CCK-8,
  cell counting kit-8 | ChIP, chromatin immunoprecipitation | CHOP, C/EBP homologous
  protein | COX-2, cyclooxygenase-2 | CVDs, cardiovascular diseases | DMEM, Dulbecco's
  modified eagle's medium | ELISA, enzyme-linked immunosorbent assay | FBS, fetal
  bovine serum | GEN, genistein | HSP90, heat shock protein 90 | IF, immunofluorescence
  | IGF-1, insulin-like growth factor-1 | IL-6, interleukin 6 | iNOS, inducible nitric
  oxide synthase | JNK, c-Jun N-terminal kinase | LDH, lactate dehydrogenase | LPS,
  lipopolysaccharide | MUT, mutant | MyD88, myeloid differentiation primary response
  88 | NF-κB, nuclear factor-kappa B | PBMCs, peripheral blood mononuclear cells |
  PBS, phosphate buffered saline | PDCD4, programmed cell death 4 | PDTC, pyrrolidine
  dithiocarbamate | PMφs, peritoneal macrophages | qRT-PCR, quantitative real-time
  polymerase chain reaction | STAT3, signal transducer and activator of transcription
  3 | TiO2 NPs, titanium dioxide nanoparticles | TIPE2, tumor necrosis factor-α-induced
  protein 8-like 2 | TLR4, toll-like receptor 4 | TNF-α, tumor necrosis factor-α |
  TRIF, Toll/IL-1R domain-containing adaptor-inducing IFN-β | WT, wild type
automl_pathway: 0.9467388
figid_alias: PMC9315303__F7
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC9315303__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9315303__gr7.html
  '@type': Dataset
  description: Working model for genistein promotes M1 macrophage apoptosis and reduces
    inflammatory response in LPS-induced cardiovascular injury. Genistein regulates
    NF-κB/miR-21/TIPE2 signaling pathway, which on the one hand leads to inhibition
    of downstream AKT phosphorylation and promotes apoptosis of M1 macrophages, and
    on the other hand down-regulates TRIF and MyD88 expressions to reduce inflammation.
    As a result, it can resist LPS-induced cardiovascular injury.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - oh
  - Tnfaip8l2
  - Mir21a
  - Rela
  - Gorasp1
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Vmp1
  - Tlr4
  - Akt1
  - Rnf138
  - Trim69
  - Ticam1
  - Ticam2
  - Myd88
  - Mir21
  - Syt1
  - TNFAIP8L2
  - MIR21
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - VMP1
  - IRF6
  - AKT1
  - AKT2
  - AKT3
  - TRIM69
  - TICAM1
  - MYD88
  - TLR4
---
